Boston Scientificvs.GE HealthCare
BSX vs GEHC · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Boston Scientific is about 2.3× larger than GE HealthCare by market cap; GE HealthCare trades at the lower P/E (15.4 vs 18.7); year to date, GE HealthCare leads (−21.1% vs −53.0%).
Side by side
| BSX | GEHC | |
|---|---|---|
| Market cap | $66.5B | $29.4B |
| Price | $44.77 | $64.70 |
| Today | −0.5% | +0.0% |
| Return YTD | −53.0% | −21.1% |
| Return 1Y | −56.9% | −15.4% |
| P/E | 18.7 | 15.4 |
| P/S | 3.2 | 1.4 |
| P/B | 2.6 | 2.8 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Boston ScientificBSX
American medtech company with strong growth in cardiology — including electrophysiology (Farapulse) and structural heart treatment.
Full BSX profile →GE HealthCareGEHC
Medical imaging (CT, MRI, ultrasound) and patient monitoring globally.
Full GEHC profile →More comparisons in Medtech & devices
See where BSX and GEHC sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →